Gordon Stephen 4
4 · TransMedics Group, Inc. · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Gordon Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-01$38.46/sh+15,000$576,900→ 38,299 total - Sale
Common Stock
2024-04-01$74.01/sh−15,000$1,110,150→ 23,299 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-01−15,000→ 37,477 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
- [F2]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.